LONDON, 2 November 2022 – Argenta, the only combined global contract research organisation (CRO) and contract development & manufacturing organisation (CDMO) specialised in animal health, announced today the appointment of Matt Applegate as the General Manager of its manufacturing location in Fort Dodge, IA, USA, effective immediately.
Working closely with the site leadership team, Matt will focus on growing the capabilities and performance of the strategically positioned manufacturing location.
Stephen Sibson, Global Head or Manufacturing at Argenta said: “Matt’s years of experience in manufacturing, process engineering, manufacturing sciences and operations management make him well-suited to advance Argenta’s growth and development. I am excited to work with Matt to further improve our contract manufacturing capabilities and build on existing partnerships with our customers.”
Prior to joining Argenta, Matt was Vice President Manufacturing and Site Director at Medgene and at Kindred Biosciences. Earlier in his career, he worked at IPS, Thermo Fisher Scientific, and Ceva Santé Animale.
Matt takes over from interim General Manager Peter Lord, who will continue in his role as Argenta’s Global Head of Supply Chain when he returns to New Zealand.
Founded in New Zealand, Argenta’s talented and committed employees are dedicated to delivering excellence to customers around the world. With research and/or GMP manufacturing operations in Germany, New Zealand, Spain, the United Kingdom, and the United States, Argenta holds a unique position as the only combined global contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) specialising in animal health.
Argenta operates from Molecule to Market in partnership with customers of all sizes from all corners of the world, supporting their research and development, clinical research, regulatory affairs, scale-up and manufacturing needs along their animal health product development journey.
The day-to-day ethos that drives Argenta forward is a mission focused on global partnerships, a Molecule to Market approach, and innovation. At the core of the business and the organisation is collaboration – among the global employee base and with their customers.
For more information, please visit www.argentaglobal.com.
Annemieke de Keijzer